Yahoo Poland Wyszukiwanie w Internecie

Search results

1. finance.yahoo.com › quote › ZLCS(ZLCS) Stock Price, News, Quote & History - Yahoo Finance

   finance.yahoo.com › quote › ZLCS

   • Zapisane w pamięci cache

   Find the latest (ZLCS) stock quote, history, news and other vital information to help you with your stock trading and investing.

2. finance.yahoo.com › quote › ZLCS(ZLCS) Latest Stock News & Headlines - Yahoo Finance

   finance.yahoo.com › quote › ZLCS

   • Zapisane w pamięci cache

   Get the latest (ZLCS) stock news and headlines to help you in your trading and investing decisions.

3. www.thestreet.com › quote › ZLCSZLCS (ZLCS) Stock Price, News & Historical Data - TheStreet

   www.thestreet.com › quote › ZLCS

   • Zapisane w pamięci cache

   8 paź 2024 · Find the latest ZLCS, ZLCS stock market data. Get a full understanding of how ZLCS is performing with stock quotes and prices, as well as real-time news and analysis.

4. www.thestreet.com › markets › why-zalicus-zlcs-stock-is-soaring-today-12672071Why Zalicus (ZLCS) Stock Is Soaring Today - TheStreet

   www.thestreet.com › markets › why-zalicus-zlcs-stock-is-soaring-today-12672071

   • Zapisane w pamięci cache

   16 kwi 2014 · Zalicus (ZLCS) soared Wednesday after the biopharmaceutical company announced it would merge with Epirus Biopharmaceuticals.

5. www.bloomberg.com › profile › companyEPIRUS Biopharmaceuticals Inc - Company Profile and News

   www.bloomberg.com › profile › company

   • Zapisane w pamięci cache

   Company profile page for EPIRUS Biopharmaceuticals Inc including stock price, company news, executives, board members, and contact information.

6. www.reuters.com › markets › companiesZLCS.O - | Stock Price & Latest News | Reuters

   www.reuters.com › markets › companies

   20 paź 2024 · Exclusive news, data and analytics for financial market professionals Learn more about Refinitiv

7. www.thestreet.com › markets › why-zalicus-zlcs-stock-is-surging-today-12742736Why Zalicus (ZLCS) Stock Is Surging Today - TheStreet

   www.thestreet.com › markets › why-zalicus-zlcs-stock-is-surging-today-12742736

   • Zapisane w pamięci cache

   Zalicus (ZLCS) surged Thursday after Epirus Switzerland announced clinical data from a Phase 3 study of BOW015, a biosimilar infliximab, in patients with active rheumatoid arthritis.